 | • レポートコード：GIR201106220 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、OTC抗感染製品の世界市場を調査対象にし、OTC抗感染製品の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（抗真菌剤、防腐剤、駆虫剤）、用途別分析（病院薬局、ドラッグストア、小売店、電子商取引）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：GlaxoSmithKline、Roche、Novartis、Merck、Bristol-Myers Squibb、Pfizer、Novabay Pharmaceuticals、Sanofi、Abbott、NanoViricides、Optimer Pharmaceuticals、Basilea Pharmaceutica、MerLion Pharma ・メーカー別販売量、売上、市場シェア ・OTC抗感染製品の地域別市場分析 ・OTC抗感染製品の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・OTC抗感染製品のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・OTC抗感染製品のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・OTC抗感染製品の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・OTC抗感染製品の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・OTC抗感染製品の種類別市場規模2015-2020：抗真菌剤、防腐剤、駆虫剤 ・OTC抗感染製品の用途別市場規模2015-2020：病院薬局、ドラッグストア、小売店、電子商取引 ・OTC抗感染製品の世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The global OTC Anti-Infective Products market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The OTC Anti-Infective Products market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
OTC Anti-Infective Products market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, OTC Anti-Infective Products market has been segmented into
Antifungals
Antiseptic
Antiparasitics
By Application, OTC Anti-Infective Products has been segmented into:
Hospital Pharmacies
Drug Stores
Retail Stores
E-Commerce
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global OTC Anti-Infective Products market presented in the report. This section sheds light on the sales growth of different regional and country-level OTC Anti-Infective Products markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global OTC Anti-Infective Products market.
The report offers in-depth assessment of the growth and other aspects of the OTC Anti-Infective Products market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and OTC Anti-Infective Products Market Share Analysis
OTC Anti-Infective Products competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, OTC Anti-Infective Products sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the OTC Anti-Infective Products sales, revenue and market share for each player covered in this report.
The major players covered in OTC Anti-Infective Products are:
GlaxoSmithKline
Roche
Novartis
Merck
Bristol-Myers Squibb
Pfizer
Novabay Pharmaceuticals
Sanofi
Abbott
NanoViricides
Optimer Pharmaceuticals
Basilea Pharmaceutica
MerLion Pharma
Among other players domestic and global, OTC Anti-Infective Products market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe OTC Anti-Infective Products product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of OTC Anti-Infective Products, with price, sales, revenue and global market share of OTC Anti-Infective Products in 2018 and 2019.
Chapter 3, the OTC Anti-Infective Products competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the OTC Anti-Infective Products breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, OTC Anti-Infective Products market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe OTC Anti-Infective Products sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 OTC Anti-Infective Products Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global OTC Anti-Infective Products Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Antifungals
1.2.3 Antiseptic
1.2.4 Antiparasitics
1.3 Market Analysis by Application
1.3.1 Overview: Global OTC Anti-Infective Products Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital Pharmacies
1.3.3 Drug Stores
1.3.4 Retail Stores
1.3.5 E-Commerce
1.4 Overview of Global OTC Anti-Infective Products Market
1.4.1 Global OTC Anti-Infective Products Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 GlaxoSmithKline
2.1.1 GlaxoSmithKline Details
2.1.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 GlaxoSmithKline SWOT Analysis
2.1.4 GlaxoSmithKline Product and Services
2.1.5 GlaxoSmithKline OTC Anti-Infective Products Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Roche
2.2.1 Roche Details
2.2.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Roche SWOT Analysis
2.2.4 Roche Product and Services
2.2.5 Roche OTC Anti-Infective Products Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Novartis SWOT Analysis
2.3.4 Novartis Product and Services
2.3.5 Novartis OTC Anti-Infective Products Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Merck
2.4.1 Merck Details
2.4.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Merck SWOT Analysis
2.4.4 Merck Product and Services
2.4.5 Merck OTC Anti-Infective Products Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Bristol-Myers Squibb
2.5.1 Bristol-Myers Squibb Details
2.5.2 Bristol-Myers Squibb Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Bristol-Myers Squibb SWOT Analysis
2.5.4 Bristol-Myers Squibb Product and Services
2.5.5 Bristol-Myers Squibb OTC Anti-Infective Products Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Pfizer
2.6.1 Pfizer Details
2.6.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Pfizer SWOT Analysis
2.6.4 Pfizer Product and Services
2.6.5 Pfizer OTC Anti-Infective Products Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Novabay Pharmaceuticals
2.7.1 Novabay Pharmaceuticals Details
2.7.2 Novabay Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Novabay Pharmaceuticals SWOT Analysis
2.7.4 Novabay Pharmaceuticals Product and Services
2.7.5 Novabay Pharmaceuticals OTC Anti-Infective Products Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Sanofi
2.8.1 Sanofi Details
2.8.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Sanofi SWOT Analysis
2.8.4 Sanofi Product and Services
2.8.5 Sanofi OTC Anti-Infective Products Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Abbott
2.9.1 Abbott Details
2.9.2 Abbott Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Abbott SWOT Analysis
2.9.4 Abbott Product and Services
2.9.5 Abbott OTC Anti-Infective Products Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 NanoViricides
2.10.1 NanoViricides Details
2.10.2 NanoViricides Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 NanoViricides SWOT Analysis
2.10.4 NanoViricides Product and Services
2.10.5 NanoViricides OTC Anti-Infective Products Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Optimer Pharmaceuticals
2.11.1 Optimer Pharmaceuticals Details
2.11.2 Optimer Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Optimer Pharmaceuticals SWOT Analysis
2.11.4 Optimer Pharmaceuticals Product and Services
2.11.5 Optimer Pharmaceuticals OTC Anti-Infective Products Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Basilea Pharmaceutica
2.12.1 Basilea Pharmaceutica Details
2.12.2 Basilea Pharmaceutica Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Basilea Pharmaceutica SWOT Analysis
2.12.4 Basilea Pharmaceutica Product and Services
2.12.5 Basilea Pharmaceutica OTC Anti-Infective Products Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 MerLion Pharma
2.13.1 MerLion Pharma Details
2.13.2 MerLion Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 MerLion Pharma SWOT Analysis
2.13.4 MerLion Pharma Product and Services
2.13.5 MerLion Pharma OTC Anti-Infective Products Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global OTC Anti-Infective Products Sales and Market Share by Manufacturer (2018-2019)
3.2 Global OTC Anti-Infective Products Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 OTC Anti-Infective Products Manufacturer Market Share in 2019
3.3.2 Top 6 OTC Anti-Infective Products Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global OTC Anti-Infective Products Sales, Revenue and Market Share by Regions
4.1.1 Global OTC Anti-Infective Products Sales and Market Share by Regions (2015-2020)
4.1.2 Global OTC Anti-Infective Products Revenue and Market Share by Regions (2015-2020)
4.2 North America OTC Anti-Infective Products Sales and Growth Rate (2015-2020)
4.3 Europe OTC Anti-Infective Products Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific OTC Anti-Infective Products Sales and Growth Rate (2015-2020)
4.5 South America OTC Anti-Infective Products Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa OTC Anti-Infective Products Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America OTC Anti-Infective Products Sales, Revenue and Market Share by Country
5.1.1 North America OTC Anti-Infective Products Sales and Market Share by Country (2015-2020)
5.1.2 North America OTC Anti-Infective Products Revenue and Market Share by Country (2015-2020)
5.2 United States OTC Anti-Infective Products Sales and Growth Rate (2015-2020)
5.3 Canada OTC Anti-Infective Products Sales and Growth Rate (2015-2020)
5.4 Mexico OTC Anti-Infective Products Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe OTC Anti-Infective Products Sales, Revenue and Market Share by Country
6.1.1 Europe OTC Anti-Infective Products Sales and Market Share by Country (2015-2020)
6.1.2 Europe OTC Anti-Infective Products Revenue and Market Share by Country (2015-2020)
6.2 Germany OTC Anti-Infective Products Sales and Growth Rate (2015-2020)
6.3 UK OTC Anti-Infective Products Sales and Growth Rate (2015-2020)
6.4 France OTC Anti-Infective Products Sales and Growth Rate (2015-2020)
6.5 Russia OTC Anti-Infective Products Sales and Growth Rate (2015-2020)
6.6 Italy OTC Anti-Infective Products Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific OTC Anti-Infective Products Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific OTC Anti-Infective Products Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific OTC Anti-Infective Products Revenue and Market Share by Regions (2015-2020)
7.2 China OTC Anti-Infective Products Sales and Growth Rate (2015-2020)
7.3 Japan OTC Anti-Infective Products Sales and Growth Rate (2015-2020)
7.4 Korea OTC Anti-Infective Products Sales and Growth Rate (2015-2020)
7.5 India OTC Anti-Infective Products Sales and Growth Rate (2015-2020)
7.6 Southeast Asia OTC Anti-Infective Products Sales and Growth Rate (2015-2020)
7.7 Australia OTC Anti-Infective Products Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America OTC Anti-Infective Products Sales, Revenue and Market Share by Country
8.1.1 South America OTC Anti-Infective Products Sales and Market Share by Country (2015-2020)
8.1.2 South America OTC Anti-Infective Products Revenue and Market Share by Country (2015-2020)
8.2 Brazil OTC Anti-Infective Products Sales and Growth Rate (2015-2020)
8.3 Argentina OTC Anti-Infective Products Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa OTC Anti-Infective Products Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa OTC Anti-Infective Products Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa OTC Anti-Infective Products Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia OTC Anti-Infective Products Sales and Growth Rate (2015-2020)
9.3 Turkey OTC Anti-Infective Products Sales and Growth Rate (2015-2020)
9.4 Egypt OTC Anti-Infective Products Sales and Growth Rate (2015-2020)
9.5 South Africa OTC Anti-Infective Products Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global OTC Anti-Infective Products Sales and Market Share by Type (2015-2020)
10.2 Global OTC Anti-Infective Products Revenue and Market Share by Type (2015-2020)
10.3 Global OTC Anti-Infective Products Price by Type (2015-2020)
11 Global OTC Anti-Infective Products Market Segment by Application
11.1 Global OTC Anti-Infective Products Sales Market Share by Application (2015-2020)
11.2 Global OTC Anti-Infective Products Revenue Market Share by Application (2015-2020)
11.3 Global OTC Anti-Infective Products Price by Application (2015-2020)
12 Market Forecast
12.1 Global OTC Anti-Infective Products Sales, Revenue and Growth Rate (2021-2025)
12.2 OTC Anti-Infective Products Market Forecast by Regions (2021-2025)
12.2.1 North America OTC Anti-Infective Products Market Forecast (2021-2025)
12.2.2 Europe OTC Anti-Infective Products Market Forecast (2021-2025)
12.2.3 Asia-Pacific OTC Anti-Infective Products Market Forecast (2021-2025)
12.2.4 South America OTC Anti-Infective Products Market Forecast (2021-2025)
12.2.5 Middle East & Africa OTC Anti-Infective Products Market Forecast (2021-2025)
12.3 OTC Anti-Infective Products Market Forecast by Type (2021-2025)
12.3.1 Global OTC Anti-Infective Products Sales Forecast by Type (2021-2025)
12.3.2 Global OTC Anti-Infective Products Market Share Forecast by Type (2021-2025)
12.4 OTC Anti-Infective Products Market Forecast by Application (2021-2025)
12.4.1 Global OTC Anti-Infective Products Sales Forecast by Application (2021-2025)
12.4.2 Global OTC Anti-Infective Products Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global OTC Anti-Infective Products Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of OTC Anti-Infective Products by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global OTC Anti-Infective Products Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 8. GlaxoSmithKline OTC Anti-Infective Products Major Business
Table 9. GlaxoSmithKline OTC Anti-Infective Products Total Revenue (USD Million) (2018-2019)
Table 10. GlaxoSmithKline SWOT Analysis
Table 11. GlaxoSmithKline OTC Anti-Infective Products Product and Services
Table 12. GlaxoSmithKline OTC Anti-Infective Products Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Roche Basic Information, Manufacturing Base and Competitors
Table 14. Roche OTC Anti-Infective Products Major Business
Table 15. Roche OTC Anti-Infective Products Total Revenue (USD Million) (2018-2019)
Table 16. Roche SWOT Analysis
Table 17. Roche OTC Anti-Infective Products Product and Services
Table 18. Roche OTC Anti-Infective Products Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Novartis Basic Information, Manufacturing Base and Competitors
Table 20. Novartis OTC Anti-Infective Products Major Business
Table 21. Novartis OTC Anti-Infective Products Total Revenue (USD Million) (2018-2019)
Table 22. Novartis SWOT Analysis
Table 23. Novartis OTC Anti-Infective Products Product and Services
Table 24. Novartis OTC Anti-Infective Products Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Merck Basic Information, Manufacturing Base and Competitors
Table 26. Merck OTC Anti-Infective Products Major Business
Table 27. Merck OTC Anti-Infective Products Total Revenue (USD Million) (2018-2019)
Table 28. Merck SWOT Analysis
Table 29. Merck OTC Anti-Infective Products Product and Services
Table 30. Merck OTC Anti-Infective Products Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 32. Bristol-Myers Squibb OTC Anti-Infective Products Major Business
Table 33. Bristol-Myers Squibb OTC Anti-Infective Products Total Revenue (USD Million) (2018-2019)
Table 34. Bristol-Myers Squibb SWOT Analysis
Table 35. Bristol-Myers Squibb OTC Anti-Infective Products Product and Services
Table 36. Bristol-Myers Squibb OTC Anti-Infective Products Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Pfizer Basic Information, Manufacturing Base and Competitors
Table 38. Pfizer OTC Anti-Infective Products Major Business
Table 39. Pfizer OTC Anti-Infective Products Total Revenue (USD Million) (2018-2019)
Table 40. Pfizer SWOT Analysis
Table 41. Pfizer OTC Anti-Infective Products Product and Services
Table 42. Pfizer OTC Anti-Infective Products Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Novabay Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 44. Novabay Pharmaceuticals OTC Anti-Infective Products Major Business
Table 45. Novabay Pharmaceuticals OTC Anti-Infective Products Total Revenue (USD Million) (2018-2019)
Table 46. Novabay Pharmaceuticals SWOT Analysis
Table 47. Novabay Pharmaceuticals OTC Anti-Infective Products Product and Services
Table 48. Novabay Pharmaceuticals OTC Anti-Infective Products Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Sanofi Basic Information, Manufacturing Base and Competitors
Table 50. Sanofi OTC Anti-Infective Products Major Business
Table 51. Sanofi OTC Anti-Infective Products Total Revenue (USD Million) (2018-2019)
Table 52. Sanofi SWOT Analysis
Table 53. Sanofi OTC Anti-Infective Products Product and Services
Table 54. Sanofi OTC Anti-Infective Products Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Abbott Basic Information, Manufacturing Base and Competitors
Table 56. Abbott OTC Anti-Infective Products Major Business
Table 57. Abbott OTC Anti-Infective Products Total Revenue (USD Million) (2018-2019)
Table 58. Abbott SWOT Analysis
Table 59. Abbott OTC Anti-Infective Products Product and Services
Table 60. Abbott OTC Anti-Infective Products Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. NanoViricides Basic Information, Manufacturing Base and Competitors
Table 62. NanoViricides OTC Anti-Infective Products Major Business
Table 63. NanoViricides OTC Anti-Infective Products Total Revenue (USD Million) (2018-2019)
Table 64. NanoViricides SWOT Analysis
Table 65. NanoViricides OTC Anti-Infective Products Product and Services
Table 66. NanoViricides OTC Anti-Infective Products Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Optimer Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 68. Optimer Pharmaceuticals OTC Anti-Infective Products Major Business
Table 69. Optimer Pharmaceuticals OTC Anti-Infective Products Total Revenue (USD Million) (2018-2019)
Table 70. Optimer Pharmaceuticals SWOT Analysis
Table 71. Optimer Pharmaceuticals OTC Anti-Infective Products Product and Services
Table 72. Optimer Pharmaceuticals OTC Anti-Infective Products Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Basilea Pharmaceutica Basic Information, Manufacturing Base and Competitors
Table 74. Basilea Pharmaceutica OTC Anti-Infective Products Major Business
Table 75. Basilea Pharmaceutica OTC Anti-Infective Products Total Revenue (USD Million) (2018-2019)
Table 76. Basilea Pharmaceutica SWOT Analysis
Table 77. Basilea Pharmaceutica OTC Anti-Infective Products Product and Services
Table 78. Basilea Pharmaceutica OTC Anti-Infective Products Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. MerLion Pharma Basic Information, Manufacturing Base and Competitors
Table 80. MerLion Pharma OTC Anti-Infective Products Major Business
Table 81. MerLion Pharma OTC Anti-Infective Products Total Revenue (USD Million) (2018-2019)
Table 82. MerLion Pharma SWOT Analysis
Table 83. MerLion Pharma OTC Anti-Infective Products Product and Services
Table 84. MerLion Pharma OTC Anti-Infective Products Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 85. Global OTC Anti-Infective Products Sales by Manufacturer (2018-2019) (K Units)
Table 86. Global OTC Anti-Infective Products Revenue by Manufacturer (2018-2019) (USD Million)
Table 87. Global OTC Anti-Infective Products Sales by Regions (2015-2020) (K Units)
Table 88. Global OTC Anti-Infective Products Sales Market Share by Regions (2015-2020)
Table 89. Global OTC Anti-Infective Products Revenue by Regions (2015-2020) (USD Million)
Table 90. North America OTC Anti-Infective Products Sales by Countries (2015-2020) (K Units)
Table 91. North America OTC Anti-Infective Products Sales Market Share by Countries (2015-2020)
Table 92. North America OTC Anti-Infective Products Revenue by Countries (2015-2020) (USD Million)
Table 93. North America OTC Anti-Infective Products Revenue Market Share by Countries (2015-2020)
Table 94. Europe OTC Anti-Infective Products Sales by Countries (2015-2020) (K Units)
Table 95. Europe OTC Anti-Infective Products Sales Market Share by Countries (2015-2020)
Table 96. Europe OTC Anti-Infective Products Revenue by Countries (2015-2020) (USD Million)
Table 97. Asia-Pacific OTC Anti-Infective Products Sales by Regions (2015-2020) (K Units)
Table 98. Asia-Pacific OTC Anti-Infective Products Sales Market Share by Regions (2015-2020)
Table 99. Asia-Pacific OTC Anti-Infective Products Revenue by Regions (2015-2020) (USD Million)
Table 100. South America OTC Anti-Infective Products Sales by Countries (2015-2020) (K Units)
Table 101. South America OTC Anti-Infective Products Sales Market Share by Countries (2015-2020)
Table 102. South America OTC Anti-Infective Products Revenue by Countries (2015-2020) (USD Million)
Table 103. South America OTC Anti-Infective Products Revenue Market Share by Countries (2015-2020)
Table 104. Middle East & Africa OTC Anti-Infective Products Sales by Countries (2015-2020) (K Units)
Table 105. Middle East & Africa OTC Anti-Infective Products Sales Market Share by Countries (2015-2020)
Table 106. Middle East & Africa OTC Anti-Infective Products Revenue by Countries (2015-2020) (USD Million)
Table 107. Middle East & Africa OTC Anti-Infective Products Revenue Market Share by Countries (2015-2020)
Table 108. Global OTC Anti-Infective Products Sales by Type (2015-2020) (K Units)
Table 109. Global OTC Anti-Infective Products Sales Share by Type (2015-2020)
Table 110. Global OTC Anti-Infective Products Revenue by Type (2015-2020) (USD Million)
Table 111. Global OTC Anti-Infective Products Revenue Share by Type (2015-2020)
Table 112. Global OTC Anti-Infective Products Sales by Application (2015-2020) (K Units)
Table 113. Global OTC Anti-Infective Products Sales Share by Application (2015-2020)
Table 114. Global OTC Anti-Infective Products Sales Forecast by Regions (2021-2025) (K Units)
Table 115. Global OTC Anti-Infective Products Market Share Forecast by Regions (2021-2025)
Table 116. Global OTC Anti-Infective Products Sales Forecast by Type (2021-2025) (K Units)
Table 117. Global OTC Anti-Infective Products Market Share Forecast by Type (2021-2025)
Table 118. Global OTC Anti-Infective Products Sales Forecast by Application (2021-2025)
Table 119. Global OTC Anti-Infective Products Market Share Forecast by Application (2021-2025)
Table 120. Direct Channel Pros & Cons
Table 121. Indirect Channel Pros & Cons
Table 122. Distributors/Traders/ Dealers List
List of Figures
Figure 1. OTC Anti-Infective Products Picture
Figure 2. Global Sales Market Share of OTC Anti-Infective Products by Type in 2019
Figure 3. Antifungals Picture
Figure 4. Antiseptic Picture
Figure 5. Antiparasitics Picture
Figure 6. OTC Anti-Infective Products Sales Market Share by Application in 2018
Figure 7. Hospital Pharmacies Picture
Figure 8. Drug Stores Picture
Figure 9. Retail Stores Picture
Figure 10. E-Commerce Picture
Figure 11. Global OTC Anti-Infective Products Market Status and Outlook (2015-2025) (USD Million)
Figure 12. United States OTC Anti-Infective Products Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Canada OTC Anti-Infective Products Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Mexico OTC Anti-Infective Products Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Germany OTC Anti-Infective Products Revenue (Value) and Growth Rate (2015-2025)
Figure 16. France OTC Anti-Infective Products Revenue (Value) and Growth Rate (2015-2025)
Figure 17. UK OTC Anti-Infective Products Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Russia OTC Anti-Infective Products Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Italy OTC Anti-Infective Products Revenue (Value) and Growth Rate (2015-2025)
Figure 20. China OTC Anti-Infective Products Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Japan OTC Anti-Infective Products Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Korea OTC Anti-Infective Products Revenue (Value) and Growth Rate (2015-2025)
Figure 23. India OTC Anti-Infective Products Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Southeast Asia OTC Anti-Infective Products Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Australia OTC Anti-Infective Products Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 26. Brazil OTC Anti-Infective Products Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Egypt OTC Anti-Infective Products Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Saudi Arabia OTC Anti-Infective Products Revenue (Value) and Growth Rate (2015-2025)
Figure 29. South Africa OTC Anti-Infective Products Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Turkey OTC Anti-Infective Products Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Global OTC Anti-Infective Products Sales Market Share by Manufacturer in 2019
Figure 32. Global OTC Anti-Infective Products Revenue Market Share by Manufacturer in 2019
Figure 33. Top 3 OTC Anti-Infective Products Manufacturer (Revenue) Market Share in 2019
Figure 34. Top 6 OTC Anti-Infective Products Manufacturer (Revenue) Market Share in 2019
Figure 35. Key Manufacturer Market Share Trend
Figure 36. Global OTC Anti-Infective Products Sales and Growth Rate (2015-2020) (K Units)
Figure 37. Global OTC Anti-Infective Products Revenue and Growth Rate (2015-2020) (USD Million)
Figure 38. Global OTC Anti-Infective Products Revenue Market Share by Regions (2015-2020)
Figure 39. Global OTC Anti-Infective Products Revenue Market Share by Regions in 2018
Figure 40. North America OTC Anti-Infective Products Sales and Growth Rate (2015-2020)
Figure 41. Europe OTC Anti-Infective Products Sales and Growth Rate (2015-2020)
Figure 42. Asia-Pacific OTC Anti-Infective Products Sales and Growth Rate (2015-2020)
Figure 43. South America OTC Anti-Infective Products Sales and Growth Rate (2015-2020)
Figure 44. Middle East & Africa OTC Anti-Infective Products Sales and Growth Rate (2015-2020)
Figure 45. North America OTC Anti-Infective Products Revenue and Growth Rate (2015-2020) (USD Million)
Figure 46. North America OTC Anti-Infective Products Sales Market Share by Countries (2015-2020)
Figure 47. North America OTC Anti-Infective Products Sales Market Share by Countries in 2018
Figure 48. North America OTC Anti-Infective Products Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 49. North America OTC Anti-Infective Products Revenue Market Share by Countries in 2018
Figure 50. United States OTC Anti-Infective Products Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Canada OTC Anti-Infective Products Sales and Growth Rate (2015-2020) (K Units)
Figure 52. Mexico OTC Anti-Infective Products Sales and Growth Rate (2015-2020) (K Units)
Figure 53. Europe OTC Anti-Infective Products Revenue and Growth Rate (2015-2020) (USD Million)
Figure 54. Europe OTC Anti-Infective Products Revenue Market Share by Countries (2015-2020)
Figure 55. Europe OTC Anti-Infective Products Revenue Market Share by Countries in 2019
Figure 56. Germany OTC Anti-Infective Products Sales and Growth Rate (2015-2020) (K Units)
Figure 57. UK OTC Anti-Infective Products Sales and Growth Rate (2015-2020) (K Units)
Figure 58. France OTC Anti-Infective Products Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Russia OTC Anti-Infective Products Sales and Growth Rate (2015-2020) (K Units)
Figure 60. Italy OTC Anti-Infective Products Sales and Growth Rate (2015-2020) (K Units)
Figure 61. Asia-Pacific OTC Anti-Infective Products Revenue and Growth Rate (2015-2020) (USD Million)
Figure 62. Asia-Pacific OTC Anti-Infective Products Sales Market Share by Regions 2019
Figure 63. Asia-Pacific OTC Anti-Infective Products Revenue Market Share by Regions 2019
Figure 64. China OTC Anti-Infective Products Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Japan OTC Anti-Infective Products Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Korea OTC Anti-Infective Products Sales and Growth Rate (2015-2020) (K Units)
Figure 67. India OTC Anti-Infective Products Sales and Growth Rate (2015-2020) (K Units)
Figure 68. Southeast Asia OTC Anti-Infective Products Sales and Growth Rate (2015-2020) (K Units)
Figure 69. South America OTC Anti-Infective Products Revenue and Growth Rate (2015-2020) (USD Million)
Figure 70. South America OTC Anti-Infective Products Sales Market Share by Countries in 2019
Figure 71. South America OTC Anti-Infective Products Revenue Market Share by Countries in 2019
Figure 72. Brazil OTC Anti-Infective Products Sales and Growth Rate (2015-2020) (K Units)
Figure 73. Argentina OTC Anti-Infective Products Sales and Growth Rate (2015-2020) (K Units)
Figure 74. Middle East and Africa OTC Anti-Infective Products Revenue and Growth Rate (2015-2020) (USD Million)
Figure 75. Middle East and Africa OTC Anti-Infective Products Sales Market Share by Countries in 2019
Figure 76. Middle East and Africa OTC Anti-Infective Products Revenue Market Share by Countries (2015-2020)
Figure 77. Middle East and Africa OTC Anti-Infective Products Revenue Market Share by Countries in 2019
Figure 78. Saudi Arabia OTC Anti-Infective Products Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Egypt OTC Anti-Infective Products Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Turkey OTC Anti-Infective Products Sales and Growth Rate (2015-2020) (K Units)
Figure 81. South Africa OTC Anti-Infective Products Sales and Growth Rate (2015-2020) (K Units)
Figure 82. Global OTC Anti-Infective Products Sales and Growth Rate (2021-2025) (K Units)
Figure 83. Global OTC Anti-Infective Products Revenue and Growth Rate (2021-2025) (USD Million)
Figure 84. North America Sales OTC Anti-Infective Products Market Forecast (2021-2025) (K Units)
Figure 85. Europe Sales OTC Anti-Infective Products Market Forecast (2021-2025) (K Units)
Figure 86. Asia-Pacific Sales OTC Anti-Infective Products Market Forecast (2021-2025) (K Units)
Figure 87. South America Sales OTC Anti-Infective Products Market Forecast (2021-2025) (K Units)
Figure 88. Middle East & Africa Sales OTC Anti-Infective Products Market Forecast (2021-2025) (K Units)
Figure 89. Sales Channel: Direct Channel vs Indirect Channel
抗感染薬の世界市場 2020年 Market Overview The global Anti-Infective Medications market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Anti-Infective Med…- 老化防止及びしわ防止製品の世界市場 2020年 Market Overview The Anti-aging and Anti-wrinkle Products market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chai…
- アンチエイジング美容製品の世界市場 2020年 Market Overview The Anti-aging Beauty Products market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiza…
- 自殺防止薬の世界市場 2020年 Market Overview The global Anti-Suicide Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Anti-Suicide Drug market re…
- バーク防止カラー（樹皮カラーなし）の世界市場 2020年 Market Overview The global Anti-Bark Collar (No Bark Collar) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Anti-Bark C…